ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group (Q71216981)
Jump to navigation
Jump to search
scientific article published on 01 April 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group |
scientific article published on 01 April 1996 |
Statements
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group (English)
R L Borison
L A Arvanitis
1 April 1996